ARTICLE | Distillery Therapeutics
Cancer
March 29, 2017 12:51 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting UBR5 could help treat triple-negative breast cancer (TNBC). In patient samples, high tumor expression of UBR5 correlated with disease ...
BCIQ Company Profiles
BCIQ Target Profiles